NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 140 filers reported holding NOVAVAX INC in Q2 2014. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $97,000 | -72.8% | 11,606 | -77.0% | 0.00% | -100.0% |
| Q3 2015 | $356,000 | -80.5% | 50,415 | -69.2% | 0.00% | -66.7% |
| Q2 2015 | $1,824,000 | +9.8% | 163,704 | -18.5% | 0.00% | 0.0% |
| Q1 2015 | $1,661,000 | -22.8% | 200,803 | -45.7% | 0.00% | -25.0% |
| Q4 2014 | $2,151,000 | +58.9% | 369,615 | +13.8% | 0.00% | +100.0% |
| Q3 2014 | $1,354,000 | -14.6% | 324,844 | -10.6% | 0.00% | -33.3% |
| Q2 2014 | $1,585,000 | -1.9% | 363,535 | +1.9% | 0.00% | 0.0% |
| Q1 2014 | $1,616,000 | -16.1% | 356,821 | +3.0% | 0.00% | -25.0% |
| Q4 2013 | $1,925,000 | +185.2% | 346,428 | +62.3% | 0.00% | +300.0% |
| Q3 2013 | $675,000 | +4400.0% | 213,399 | +2876.7% | 0.00% | – |
| Q2 2013 | $15,000 | – | 7,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
| Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
| Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
| Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
| Bellevue Group AG | 325,000 | $410,000 | 0.08% |
| Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
| Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
| Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
| Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
| Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |